McLoughlin Margaret (CIK 0001770823)

Latest company ownership

Shares held
27,000
Last filed at
Jun 7, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Aug 8, 2023 Aug 9, 2023 Quince Therapeutics, Inc. Director Buy 90.0 +8,000 100.00% $9.8K
Oct 8, 2021 Oct 12, 2021 Quince Therapeutics, Inc. Director Sell 10.0 -1,000 -100.00% $88.9K
Aug 16, 2021 Aug 18, 2021 Quince Therapeutics, Inc. Director Sell 7.5 -6,000 -100.00% $572.6K
Jun 28, 2021 Jun 29, 2021 Quince Therapeutics, Inc. Director Sell 13.8 -550 -100.00% $30.3K
May 13, 2019 Mar 12, 2020 Quince Therapeutics, Inc. Director Buy 90.0 +550 100.00% $9.4K